By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cellular Biomedicine Group 

530 University Avenue
Suite 17
Palo Alto  California  94301  U.S.A.
Phone: 1-650-566-5064 Fax: n/a



Company News
Cellular Biomedicine Group (CBMG) (CBMG) Announces Publication Titled "Target Cell Killing Effects Of CD20 Targeting Chimeric Antigen Receptor T Cells Derived From The Type Ii Anti-CD20 Antibody" In Conjunction With 2017 ASCO Annual Meeting 5/22/2017 12:25:15 PM
Cellular Biomedicine Group (CBMG) And GE Healthcare Life Sciences China Announce Strategic Partnership To Establish Joint Technology Laboratory To Develop Control Processes For The Manufacture Of CAR-T And Stem Cell Therapies 4/10/2017 8:49:42 AM
Cellular Biomedicine Group (CBMG) Announces Completion Of Wuxi GMP Facility Expansion 3/30/2017 12:14:17 PM
Cellular Biomedicine Group (CBMG) Awarded $2.29 Million Grant From The California Institute For Regenerative Medicine (CIRM) To Fund AlloJoin Allogeneic Stem Cell Therapy For Knee Osteoarthritis (KOA) In The U.S. 2/27/2017 8:03:27 AM
Cellular Biomedicine Group (CBMG), A China-US Biopharma, Starts China Trial Of CAR-T Immunotherapy 12/1/2016 9:08:33 AM
Cellular Biomedicine Group (CBMG) Lands $43 Million From Wuhan Dangdai 2/8/2016 9:06:05 AM
Cellular Biomedicine Group (CBMG) To Present At The Piper Jaffray 27th Annual Healthcare Investor Conference 11/24/2015 10:53:05 AM
Cellular Biomedicine Group (CBMG) Opens Beijing Facility 11/10/2015 1:07:30 PM
Cellular Biomedicine Group (CBMG) Presented Phase IIa Results From CAR-T CD20 Immuno-Oncology Clinical Development Program for Advanced B-cell Non-Hodgkin Lymphoma 10/28/2015 3:07:34 PM
Cellular Biomedicine Group (CBMG) To Present Phase Iia Results From CAR-T CD20 Immuno-Oncology Clinical Development Program For Advanced Diffuse Large B Cell Lymphoma 10/23/2015 10:41:59 AM